WeVote
Log In

Bill

Bill

HR 4

Resolution in Support of Petition to FDA on LED lights.

2026 Regular Session Introduced by Corby Dillon and 1 co-sponsor

WV endorses FDA action to study health and safety risks of LED lighting and report to Congress within 365 days, with potential standards and recalls.

To House Health and Human Resources
#resolutions
0
WeVote Research Nonpartisan
Bill Summary · HR 4

Summary of HR 4 (2026) – West Virginia

Purpose and intent

  • Expressions of support by the West Virginia House of Delegates for the Soft Lights Foundation’s petition to the U.S. Food and Drug Administration (FDA).
  • The petition seeks FDA action to study and report to Congress on health, safety, and civil rights impacts of flat panel LED lights (including household, indoor, street, and commercial lighting) and vehicle LED lights (headlights, strobes on emergency, utility, and construction vehicles).

Key provisions and changes proposed

  • Endorsement of FDA action under 21 U.S.C. § 360jj(a)(2) and related authorities to:
    • Conduct studies on photobiological, neurological, psychological, hormonal, and other health risks posed by LED lighting.
    • Produce a comprehensive report to Congress within 365 days detailing hazards, exposure-reduction strategies, and inter-agency coordination to establish performance standards.
  • Issues highlighted for study and potential regulation include:
    • Safety defects: excessive brightness, glare, halos, afterimages, and increased accident risk.
    • Blue-rich color temperatures: suppression of melatonin, circadian disruption, and associations with various health conditions (obesity, certain cancers, cardiovascular disease, Alzheimer's, mental health issues).
    • Flicker and pulsing emissions: migraines, seizures, sensory overload, panic, and other neurological effects.
    • Design flaws: misalignment, insufficient shielding, over-illumination, and ecological light pollution.
  • Proposed regulatory responses and standards (as advocated by the petition):
    • Brightness limits and warmer color temperatures (targeted ranges of ≤2,700K–3,000K).
    • Flicker-free designs, shielding/diffusers, proper aiming/alignment.
    • Dimmable/adaptive features and restrictions on aftermarket LED modifications.
    • Annual inspections and LED-free zones in sensitive areas (e.g., hospitals).
    • Promotion of safer alternatives (reinstating incandescent/halogen options) and national light pollution laws.
    • Recalls, public education, and accommodations for affected individuals.
  • Public health focus specific to West Virginia:
    • Emphasizes impacts on vulnerable populations (e.g., individuals with epilepsy, migraines, photophobia, and other sensitivities) and on rural, low-light regions where lighting may affect safety and roadways.
    • Cites numerous reports and studies cited by the petition to support concern over health and safety risks.

Who and what would be affected

  • LED lighting products used in homes, workplaces, streets, public facilities, and vehicles (including emergency and construction vehicle lighting).
  • Government agencies and regulatory processes:
    • FDA would be urged to initiate post-market surveillance, radiation control considerations, and inter-agency collaboration.
    • Potential coordination with NHTSA, CPSC, DOE, EPA, OSHA, and DOT for standards and enforcement.
  • West Virginia residents, particularly vulnerable groups and communities in rural areas, with potential impacts on health, safety, mobility, and access to public spaces.

Procedural and timeline aspects

  • Status: Introduced in the West Virginia House of Delegates on January 27, 2026.
  • Referral: Health and Human Resources Committee, then Rules.
  • Action requested: The resolution urges the FDA to grant the petition, conduct studies, and submit a report to Congress within 365 days, plus establish related safety and regulatory actions.
  • Advocacy: The resolution also calls on West Virginia’s congressional delegation to press for the petition’s objectives and any supporting federal actions.

Official actions and sponsors

  • Primary sponsors: Delegates Corby Dillon and Laura Kimble (co-sponsors).
  • The resolution expresses formal support and directs communications to the FDA Commissioner, Soft Lights Foundation, the Governor of West Virginia, and members of the state’s congressional delegation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.